Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
Meningococcal Conjugate Vaccine | Menactra® (Meningococcal [Groups A, C, Y, and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine)
Menactra is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Menactra is approved for use in individuals 9 months through 55 years of age. Menactra does not prevent N meningitidis serogroup B disease. Please see Important Safety Information and full Prescribing Information on the website.
This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for menactra.com: 18.67.65.68, 18.67.65.75, 18.67.65.76, 18.67.65.127. Moreover, DNS used with this website include ns1.sanofi-synthelabo.com, ns2.sanofi-synthelabo.com, ns3.sanofi-synthelabo.com, ns4.sanofi-synthelabo.com. Subnet identifier ranges from 18.64.0.0 to 18.67.255.255. Classless Inter-Domain Routing (CIDR) is 18.64.0.0/14. ARIN net type is Reallocated.
Last scanned
Domain Age
Daily Visitors
Global Rank
ns1.sanofi-synthelabo.com
ns2.sanofi-synthelabo.com
ns3.sanofi-synthelabo.com
ns4.sanofi-synthelabo.com
{{value}}
2001-04-23
2024-04-23
CSC CORPORATE DOMAINS, INC.
{{value}}
The registrar of menactra.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2024-04-23. According to open source data, you can reach the owner at domain.names@sanofi.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
5.8K
13.9K
N/A
N/A
946.9K
N/A
N/A
N/A
340.1K
534